Artiva Biotherapeutics, Inc.'s total assets for Q4 2025 were $130.94M, a decrease of -12.04% from the previous quarter. ARTV total liabilities were $20.97M for the fiscal quarter, a 6.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.